Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C.

J Clin Invest. 2004 Oct;114(8):1058-71.

2.

Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.

Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, Patterson C.

J Clin Invest. 2007 Nov;117(11):3211-23.

3.

MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Baskin KK, Rodriguez MR, Kansara S, Chen W, Carranza S, Frazier OH, Glass DJ, Taegtmeyer H.

J Mol Cell Cardiol. 2014 Jul;72:168-76. doi: 10.1016/j.yjmcc.2014.03.006.

4.

Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.

Li JJ, Zhang TP, Meng Y, Du J, Li HH.

Cell Physiol Biochem. 2011;27(5):463-70. doi: 10.1159/000329967.

5.

FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle.

Maragno AL, Baqui MM, Gomes MD.

Biochim Biophys Acta. 2006 Jun;1760(6):966-72.

PMID:
16714087
6.

Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.

Bornstein G, Ganoth D, Hershko A.

Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11515-20.

7.

Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.

Zhou W, Wei W, Sun Y.

Cell Res. 2013 May;23(5):599-619. doi: 10.1038/cr.2013.44. Review.

8.

Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.

Maejima Y, Usui S, Zhai P, Takamura M, Kaneko S, Zablocki D, Yokota M, Isobe M, Sadoshima J.

Circ Heart Fail. 2014 May;7(3):479-90. doi: 10.1161/CIRCHEARTFAILURE.113.000713.

9.

Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.

Isobe T, Hattori T, Kitagawa K, Uchida C, Kotake Y, Kosugi I, Oda T, Kitagawa M.

J Biol Chem. 2009 Oct 9;284(41):27766-79. doi: 10.1074/jbc.M109.006809.

10.
11.

Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes.

Zeng Y, Li J, Wang HX, Guo SB, Yang H, Zeng XJ, Fang Q, Tang CS, Du J, Li HH.

PLoS One. 2013;8(1):e53831. doi: 10.1371/journal.pone.0053831. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/97e1be8b-a068-4e4b-9e8d-14315bb34e7e. Li, Junjie [added].

12.

The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.

Song DW, Ryu JY, Kim JO, Kwon EJ, Kim DH.

Biochem J. 2014 Jan 1;457(1):151-62. doi: 10.1042/BJ20130833.

PMID:
24117217
13.

Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.

Usui S, Maejima Y, Pain J, Hong C, Cho J, Park JY, Zablocki D, Tian B, Glass DJ, Sadoshima J.

Circ Res. 2011 Jul 8;109(2):161-71. doi: 10.1161/CIRCRESAHA.110.238717.

14.

Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.

Gonçalves DA, Lira EC, Baviera AM, Cao P, Zanon NM, Arany Z, Bedard N, Tanksale P, Wing SS, Lecker SH, Kettelhut IC, Navegantes LC.

Endocrinology. 2009 Dec;150(12):5395-404. doi: 10.1210/en.2009-0428.

PMID:
19837877
15.

Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.

Gorelik M, Orlicky S, Sartori MA, Tang X, Marcon E, Kurinov I, Greenblatt JF, Tyers M, Moffat J, Sicheri F, Sidhu SS.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3527-32. doi: 10.1073/pnas.1519389113.

17.

Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.

Yamamoto Y, Hoshino Y, Ito T, Nariai T, Mohri T, Obana M, Hayata N, Uozumi Y, Maeda M, Fujio Y, Azuma J.

Cardiovasc Res. 2008 Jul 1;79(1):89-96. doi: 10.1093/cvr/cvn076.

PMID:
18346979
18.

You spin me round: MaFBx/Atrogin-1 feeds forward on FOXO transcription factors (like a record).

Schisler JC, Willis MS, Patterson C.

Cell Cycle. 2008 Feb 15;7(4):440-3. Review.

PMID:
18235241
19.

A refined two-hybrid system reveals that SCF(Cdc4)-dependent degradation of Swi5 contributes to the regulatory mechanism of S-phase entry.

Kishi T, Ikeda A, Koyama N, Fukada J, Nagao R.

Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14497-502. doi: 10.1073/pnas.0806253105.

20.

PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.

Jeong D, Kim JM, Cha H, Oh JG, Park J, Yun SH, Ju ES, Jeon ES, Hajjar RJ, Park WJ.

Circ Res. 2008 Mar 28;102(6):711-9. doi: 10.1161/CIRCRESAHA.107.165985.

Supplemental Content

Support Center